These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 19938950)
21. In vitro and in vivo evaluation of anti-inflammatory agents using nanoengineered alginate carriers: towards localized implant inflammation suppression. Jayant RD; McShane MJ; Srivastava R Int J Pharm; 2011 Jan; 403(1-2):268-75. PubMed ID: 21050881 [TBL] [Abstract][Full Text] [Related]
22. Microparticulate polyelectrolyte complexes for gentamicin transport across intestinal epithelia. Iannuccelli V; Montanari M; Bertelli D; Pellati F; Coppi G Drug Deliv; 2011 Jan; 18(1):26-37. PubMed ID: 20726809 [TBL] [Abstract][Full Text] [Related]
23. Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease. Oshi MA; Naeem M; Bae J; Kim J; Lee J; Hasan N; Kim W; Im E; Jung Y; Yoo JW Carbohydr Polym; 2018 Oct; 198():434-442. PubMed ID: 30093020 [TBL] [Abstract][Full Text] [Related]
25. Co-delivery of zinc and 5-aminosalicylic acid from alginate/N-succinyl-chitosan blend microspheres for synergistic therapy of colitis. Duan H; Lü S; Qin H; Gao C; Bai X; Wei Y; Wu X; Liu M; Zhang X; Liu Z Int J Pharm; 2017 Jan; 516(1-2):214-224. PubMed ID: 27851980 [TBL] [Abstract][Full Text] [Related]
26. The Influence of Chitosan Cross-linking on the Properties of Alginate Microparticles with Metformin Hydrochloride-In Vitro and In Vivo Evaluation. Szekalska M; Sosnowska K; Zakrzeska A; Kasacka I; Lewandowska A; Winnicka K Molecules; 2017 Jan; 22(1):. PubMed ID: 28117747 [TBL] [Abstract][Full Text] [Related]
27. Colonic delivery of carboxyfluorescein by pH-sensitive microspheres in experimental colitis. Kietzmann D; Moulari B; Béduneau A; Pellequer Y; Lamprecht A Eur J Pharm Biopharm; 2010 Oct; 76(2):290-5. PubMed ID: 20600885 [TBL] [Abstract][Full Text] [Related]
28. Central composite design for the formulation and optimization of a multi-unit potential colonic drug delivery system of budesonide for ulcerative colitis. Patel NV; Patel JK; Shah SH; Patel JN Pharmazie; 2011 Feb; 66(2):124-9. PubMed ID: 21434575 [TBL] [Abstract][Full Text] [Related]
29. Factorial design analysis and optimisation of alginate-Ca-chitosan microspheres. Makraduli L; Crcarevska MS; Geskovski N; Dodov MG; Goracinova K J Microencapsul; 2013; 30(1):81-92. PubMed ID: 22746546 [TBL] [Abstract][Full Text] [Related]
30. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review. George M; Abraham TE J Control Release; 2006 Aug; 114(1):1-14. PubMed ID: 16828914 [TBL] [Abstract][Full Text] [Related]
31. Alginate microspheres of isoniazid for oral sustained drug delivery. Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732 [TBL] [Abstract][Full Text] [Related]
32. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon. Krishnamachari Y; Madan P; Lin S Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982 [TBL] [Abstract][Full Text] [Related]
33. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease. Yadav VR; Suresh S; Devi K; Yadav S J Pharm Pharmacol; 2009 Mar; 61(3):311-21. PubMed ID: 19222903 [TBL] [Abstract][Full Text] [Related]
34. Synbiotic loaded chitosan-Ca-alginate microparticles reduces inflammation in the TNBS model of rat colitis. Ivanovska TP; Mladenovska K; Zhivikj Z; Pavlova MJ; Gjurovski I; Ristoski T; Petrushevska-Tozi L Int J Pharm; 2017 Jul; 527(1-2):126-134. PubMed ID: 28552770 [TBL] [Abstract][Full Text] [Related]
35. Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system. Coppi G; Iannuccelli V Int J Pharm; 2009 Feb; 367(1-2):127-32. PubMed ID: 18940240 [TBL] [Abstract][Full Text] [Related]
36. Diffusion loading and drug delivery characteristics of alginate gel microparticles produced by a novel impinging aerosols method. Hariyadi DM; Lin SC; Wang Y; Bostrom T; Turner MS; Bhandari B; Coombes AG J Drug Target; 2010 Dec; 18(10):831-41. PubMed ID: 20958098 [TBL] [Abstract][Full Text] [Related]
37. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization. Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of the diffusion coefficient for controlled release of oxytetracycline from alginate/chitosan/poly(ethylene glycol) microbeads in simulated gastrointestinal environments. Cruz MC; Ravagnani SP; Brogna FM; Campana SP; Triviño GC; Lisboa AC; Mei LH Biotechnol Appl Biochem; 2004 Dec; 40(Pt 3):243-53. PubMed ID: 15281914 [TBL] [Abstract][Full Text] [Related]
39. Assessment of anticolitic drugs in the trinitrobenzene sulfonic acid (TNBS) rat model of inflammatory bowel disease. Whittle BJ; Cavicchi M; Lamarque D Methods Mol Biol; 2003; 225():209-22. PubMed ID: 12769490 [No Abstract] [Full Text] [Related]
40. Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds. Balakrishnan B; Jayakrishnan A Biomaterials; 2005 Jun; 26(18):3941-51. PubMed ID: 15626441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]